At Genentech, a member of the Roche Group, I addressed 550 executives in San Francisco and challenged them to think beyond breakthrough science toward the broader reinvention made possible by exponential genomics.

The keynote, “Personalized Medicine in the Era of Exponential Genomics,” made the case that personalized medicine was moving from possibility to platform.

Genentech: Personalized Medicine Was Moving From Possibility To Platform

Targeted therapies, genetic profiles, accelerating science and next generation healthcare were no longer separate initiatives. They were becoming one connected system.

The future of healthcare is individualized, data rich, science driven and fast.

Personalized medicine is one of the themes I keep returning to on stage. The same pattern, science moving faster than the organizations built to apply it, keeps showing up across industries. You can browse more of that work in the case studies collection here.